POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Aging is associated with reduced performance in multiple domains of cognition: memory, executive functions (planning, inhibition, manipulating information in one’s mind), language, processing ...
Scientists investigating Alzheimer's disease have made a key breakthrough. They have identified a vital cellular mechanism driving the most common cause of dementia. American researchers say the ...
There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto. In a study published in 2023, ...
Research on Alzheimer’s disease is approaching a much-needed tipping point. The media spotlight has been on newly available drugs like lecanemab and donanemab that target the protein plaques ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's disease, the road to a cure seems long and uncertain. But as the year comes to a close, experts are ...
Reminiscence refers to the act of recalling memories from the past. It is a familiar activity to everyone, but reminiscence can be highly beneficial for people with Alzheimer’s disease. It can support ...
Alzheimer's disease affects memory, thinking and behaviour, and while age stands as the predominantly known risk factor, your lifestyle choices can also sway the odds. An enlightening article ...